Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

35.28
Delayed Data
As of Nov 20
 -0.63 / -1.75%
Today’s Change
29.83
Today|||52-Week Range
47.75
-22.08%
Year-to-Date

Today’s Trading

Previous close35.91
Today’s open35.00
Day’s range34.98 - 35.35
Volume347,233
Average volume (3 months)366,994
Market cap$6.0B
Dividend yield0.89%
Data as of 4:02pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)-39.73%
Earnings growth (this year)+8.01%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)-10.90%
P/E ratio33.9
Price/Sales3.19
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.08-0.34%
CTLTCatalent Inc+0.30+0.79%
----
UTHRUnited Therapeutics ...+3.18+2.58%
Data as of 4:15pm ET, 11/20/2017

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$0.34
Annual revenue (last year)$2.1B
Annual profit (last year)$179.6M
Net profit margin8.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts